Frontiers in Immunology, Section “Immunotherapies and Vaccines” |
| Regulation of Interferon Gamma Signaling by Suppressors of Cytokine Signaling and Regulatory T Cells |
| Joseph Larkin, Chulbul M. Ahmed, Tenisha D. Wilson, and Howard M Johnson |
| Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100 |
| Kevin Yee-Bien Tse, Ayelet Gonen, John Sidney, Hui Ouyang, Joseph L Witztum, Alessandro Sette, Harley Y Tse, and Klaus Ley |
| Allergy to Uncommon Pets: New Allergies but the Same Allergens |
| Araceli Diaz-Perales, David González-de-Olano, Marina Perez-Gordo, and CARLOS PASTOR-VARGAS |
| Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant |
| Catarina Joelma Magalhães Braga, Juliana Falcão Rodrigues, Yordanka Medina-Armenteros, Luis Ernesto Farinha-Arcieri, Armando Morais Ventura, Silvia Beatriz Boscardin, Maria Elisabete Sbrogio-Almeida, and Luis Carlos de Souza Ferreira |
Frontiers in Immunology, Section “Inflammation” |
| Analytical Tools for the Study of Cellular Glycosylation in the Immune System |
| Yvette Van Kooyk, Hakan Kalay, and Juan J. Garcia-Vallejo |
| Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study. |
| ERIC TOUSSIROT, Emilie Grandclement, Beatrice Gaugler, Fabrice Michel, daniel Wendling, Philippe Saas, Gilles Dumoulin, and cic bt |
| Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34+ Progenitor Cells |
| Zoulfia Allakhverdi, Michael R Comeau, Myriam Armant, Rachana Agrawal, Judith A Woodfolk, Roma Sehmi, Karen J Howie, Gail M Gauvreau, and Guy Delespesse |
| Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity |
| David Anak Simon Davis and Christopher Richard Parish |
| The Role of Ubiquitination in TWEAK-Stimulated Signaling |
| Domagoj Vucic |
| A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes |
| Wai Wai Lin, Joanne Marie Hildebrand, and Gail Abendroth Bishop |
| TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine |
| Denise Louise Faustman and Miriam Davis |
| TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic |
| Emily Cheng, Cheryl L. Armstrong, Rebeca Galisteo, and Jeffrey A Winkles |
| l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice |
| Maritza J Romero, Lin Yao, Supriya Sridhar, Anil Bhatta, Huijuan Dou, Ganesan Ramesh, Michael W Brands, David M Pollock, Ruth B Caldwell, Stephen D Cederbaum, C Alvin Head, Zsolt Bagi, Rudolf Lucas, and Robert William Caldwell |
| Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway |
| Chaim Putterman |
| Heparanase and Autoimmune Diabetes |
| Charmaine Joy Simeonovic, Andrew Ziolkowski, Zuopeng Wu, Fui Jiun Choong, Craig Freeman, and Christopher Parish |
| Dendritic Cells: A Spot on Sialic Acid |
| Hélio João Crespo, Joseph T.Y. Lau, and Paula Alexandra Videira |
| Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases? |
| Daniel Bertin, Delphine Stephan, Michel Khrestchatisky, and Sophie Desplat-Jégo |
|
|
Frontiers in Immunology, Section “Molecular Innate Immunity” |
| Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress? |
| Lisa Helene Butterfield |
| Interactions between Nod-Like Receptors and Intestinal Bacteria |
| Marcel R de Zoete and Richard A Flavell |
| Sensing Microbial RNA in the Cytosol |
| Nicolas VABRET and Julie Magarian Blander |
| Debug Your Bugs – How NLRs Shape Intestinal Host-Microbe Interactions |
| Philip Rosenstiel and Simone Lipinski |
| Licensing Adaptive Immunity by NOD-Like Receptors |
| Dong Liu, Anne Marie Rhebergen, and Stephanie C Eisenbarth |
| Rapid Detection of Dendritic Cell and Monocyte Disorders Using CD4 as a Lineage Marker of the Human Peripheral Blood Antigen-Presenting Cell Compartment |
| Laura Jardine, Dawn Barge, Ashley Ames-Draycott, Sarah Pagan, Sharon Cookson, Gavin Spickett, Muzlifah Haniffa, Matthew Collin, and Venetia Bigley |
Frontiers in Immunology, Section “NK Cell Biology” |
| Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells |
| Fanny Guimont-Desrochers and Sylvie Lesage |
| Perforinopathy: A Spectrum of Human Immune Disease Caused by Defective Perforin Delivery or Function |
| Joseph A. Trapani and Ilia Voskoboinik |
| Regulation of Mouse NK Cell Development and Function by Cytokines |
| Antoine Marçais, Sébastien Viel, Morgan Grau, Thomas Henry, Jacqueline Marvel, and Thierry Walzer |
| Impact of HCMV Infection on NK Cell Development and Function after HSCT |
| Mariella Della Chiesa, Michela Falco, Letizia Muccio, Alice Bertaina, Franco Locatelli, and Alessandro Moretta |
| Graded Defects in Cytotoxicity Determine Severity of Hemophagocytic Lymphohistiocytosis in Humans and Mice |
| Birthe Jessen, Tamara Kögl, Fernando E. Sepulveda, Genevieve de Saint Basile, Peter Aichele, and Stephan Ehl |
| Natural Killer Cells Modulation in Hematological Malignancies |
| Celine Baier, Aurore Fino, Laure Farnault, Carole Sanchez, Pascal Rihet, Brigitte Kahn-Perles, and Régis Thierry Costello |
| Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells |
| Ashley Mentlik James, Adam D. Cohen, and Kerry S. Campbell |
| The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity |
| Joanna Baginska, Elodie Viry, Jérôme Paggetti, Sandrine Medves, Guy Berchem, Etienne Moussay, and Bassam Janji |
| Signatures of Human NK Cell Development and Terminal Differentiation |
| Merlin Luetke-Eversloh, Monica Killig, and Chiara Romagnani |
| The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells |
| Cristina Cerboni, Cinzia Fionda, Alessandra Soriani, Alessandra Zingoni, Margherita Doria, Marco Cippitelli, and Angela Santoni |
Frontiers in Immunology, Section “T Cell Biology” |
| Mathematical Models of the Impact of IL2 Modulation Therapies on T Cell Dynamics |
| Kalet Leon, Karina Garcia-Martinez, and Tania Carmenate |
| Cognate Antigen Stimulation Generates Potent CD8+ Inflammatory Effector T Cells |
| Hsueh-Cheng Sung, Sara Lemos, Patricia Ribeiro-Santos, Kateryna Kozryska, Florence Vasseur, Agnes Legrand, Alain Charbit, Benedita Rocha, and Cesar Evaristo |
| Preparing Unbiased T-Cell Receptor and Antibody cDNA Libraries for the Deep Next Generation Sequencing Profiling |
| Ilgar Z Mamedov, Olga V Britanova, Ivan V Zvyagin, Maria A Turchaninova, Dmitriy A Bolotin, Ekaterina V Putintseva, Yuriy B Lebedev, and Dmitriy M Chudakov |
| Mathematical Model of Naive T Cell Division and Survival IL-7 Thresholds |
| Carmen Molina-Paris, Joseph Reynolds, Grant Lythe, and Mark Christopher Coles |
| Mother and Child T Cell Receptor Repertoires: Deep Profiling Study |
| Ekaterina V Putintseva, Olga V Britanova, Dmitriy B Staroverov, Ekaterina M Merzlyak, Maria A Turchaninova, M Shugay, Dmitriy A Bolotin, Mikhail V Pogorelyy, Ilgar Z Mamedov, Vlasta Bobrynina, Mikhail Maschan, Yuri B Lebedev, and Dmitriy M Chudakov |
| Huge Overlap of Individual TCR Beta Repertoires |
| Mikhail Shugay, Dmitriy A Bolotin, Ekaterina V Putintseva, Mikhail V Pogorelyy, Ilgar Z Mamedov, and Dmitriy M Chudakov |
| A Mathematical Model of Immune Activation with a Unified Self-Nonself Concept |
| Sahamoddin Khailaie, Fariba Bahrami, Mahyar Janahmadi, Pedro Milanez-Almeida, Jochen Huehn, and Michael Meyer-Hermann |
| Estimating the Diversity, Completeness, and Cross-Reactivity of the T Cell Repertoire |
| Veronika Zarnitsyna, Brian Evavold, Louie Schoettle, Joseph Blattman, and Rustom Antia |
Frontiers in Immunology, Section “Tumor Immunity” |
| Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity |
| Aleksandra Maria Dudek, Shaun Martin, Abhishek Dinkarnath Garg, and Patrizia Agostinis |
| Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells |
| Amandine Legat, Daniel E Speiser, Hanspeter Pircher, Dietmar Zehn, and Silvia A Fuertes Marraco |
| Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response |
| Giovanna Schiavoni, Fabrizio Mattei, and Lucia Gabriele |
| Dendritic Cell-Based Immunotherapy for Myeloid Leukemias |
| Christian Martijn Schürch, Carsten Riether, and Adrian Ochsenbein |
| Therapeutic Implications of Immunogenic Cell Death in Human Cancer |
| Fabio Palombo, Chiara Focaccetti, and Vincenzo Barnaba |
|
